Profile picture

Doctor Luigi Spadafora

Sapienza University of Rome, Latina (Italy)
Membership: ESC Professional Member EAPC Member EAPCI Member HFA Member
Follow
Biography
Luigi Spadafora is a cardiologist at Ospedale Santa Maria Goretti in Latina, Italy, and a PhD student in Experimental Medicine at Sapienza University of Rome. He serves as Associate Editor for the Journal of Cardiovascular Pharmacology and is a member of the Board of the Italian Society of Cardiology, Lazio regional section. He holds a Master’s degree in Epidemiology and Biostatistics from the Catholic University of the Sacred Heart in Rome and is a Fellow of the Italian Society of Cardiology. He is fully certified in heart failure by the Heart Failure Association. His main fields of interest include coronary artery disease, interventional cardiology, cardio-oncology, and heart failure.
Logo ESC

Contributor content

Benefits of physiology-guided complete revascularization of non-culprit lesions in elderly patients with myocardial infarction across the spectrum of GRACE score: insights from the FIRE  trial.
Presentation
Benefits of physiology-guided complete revascularization of non-culprit lesions in elderly patients with myocardial infarction across the spectrum of GRACE score: insights from the FIRE trial.
SGLT2 inhibitors improve cardiovascular clinical outcomes in patients undergoing anthracycline chemotherapy: a systematic review and meta-analysis of 13,333  patients.
Presentation
SGLT2 inhibitors improve cardiovascular clinical outcomes in patients undergoing anthracycline chemotherapy: a systematic review and meta-analysis of 13,333 patients.
One-year clinical outcomes of NSTEMI patients according to left ventricular ejection fraction: data from a large multicenter registry.
Presentation
One-year clinical outcomes of NSTEMI patients according to left ventricular ejection fraction: data from a large multicenter registry.
Features and predictors of 1-year outcomes in cancer patients discharged after acute coronary syndrome: insights from a multicenter registry.
Presentation
Features and predictors of 1-year outcomes in cancer patients discharged after acute coronary syndrome: insights from a multicenter registry.
Higher systolic pulmonary artery pressure as a predictor of anthracycline-induced cardiac dysfunction in patients with hematologic malignancies.
Presentation
Higher systolic pulmonary artery pressure as a predictor of anthracycline-induced cardiac dysfunction in patients with hematologic malignancies.
Impact of different types of hematologic disorders on anthracycline-induced cardiotoxicity: a retrospective analysis.
Presentation
Impact of different types of hematologic disorders on anthracycline-induced cardiotoxicity: a retrospective analysis.
Clinical predictors of one-year mortality in STEMI patients across the spectrum of LVEF: insights from a large multicenter registry.
Presentation
Clinical predictors of one-year mortality in STEMI patients across the spectrum of LVEF: insights from a large multicenter registry.
Regional disparities in STEMI management and outcomes in italy: an analysis of time-dependent reperfusion networks and in-hospital logistics
Presentation
Regional disparities in STEMI management and outcomes in italy: an analysis of time-dependent reperfusion networks and in-hospital logistics
Hemoglobin/creatinine ratio as long- term prognostic marker in acute coronary syndromes: a praise registry study.
Presentation
Hemoglobin/creatinine ratio as long- term prognostic marker in acute coronary syndromes: a praise registry study.

ESC 365 is supported by